pharma · Metachromatic Leukodystrophy (MLD) · Late Metachromatic Leukodystrophy (MLD)
Shire
Shire is a pharma organization headquartered in CN. Primary therapeutic focus areas include Metachromatic Leukodystrophy (MLD), Late Metachromatic Leukodystrophy (MLD), Hunter Syndrome, Cytomegalovirus (CMV), Crohn's Dis
JP HQ
3,523 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- JP
- Employees
- 3,523
- Programs
- 9
- Drugs
- 8
- Patents
- 0
Ontamalimab
Phase 3 · small molecule · Crohn's Disease
Ontamalimab for Crohn's Disease is a Phase 3 program (small_molecule) at Shire with 1 ClinicalTrials.gov record(s).
Internal code SHP647-307
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shire
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Crohn's Disease
- Status
- terminated
- Trials
- 1